CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,629,548 | -19.1% | 498,558 | 0.0% | 12.03% | -63.8% |
| Q2 2023 | $27,989,046 | +24.1% | 498,558 | 0.0% | 33.20% | -29.4% |
| Q1 2023 | $22,549,778 | +11.3% | 498,558 | 0.0% | 47.01% | +12.1% |
| Q4 2022 | $20,266,383 | -37.8% | 498,558 | 0.0% | 41.94% | -24.5% |
| Q3 2022 | $32,581,000 | +7.5% | 498,558 | 0.0% | 55.55% | +19.6% |
| Q2 2022 | $30,297,000 | -3.2% | 498,558 | 0.0% | 46.45% | +48.7% |
| Q1 2022 | $31,294,000 | -17.2% | 498,558 | 0.0% | 31.24% | +54.6% |
| Q4 2021 | $37,781,000 | -32.3% | 498,558 | 0.0% | 20.21% | -12.6% |
| Q3 2021 | $55,804,000 | -32.2% | 498,558 | -2.0% | 23.11% | -15.3% |
| Q2 2021 | $82,330,000 | -56.5% | 508,558 | -67.3% | 27.28% | -26.1% |
| Q1 2021 | $189,472,000 | -59.3% | 1,554,960 | -48.9% | 36.92% | -23.6% |
| Q4 2020 | $465,525,000 | +53.3% | 3,040,462 | -16.3% | 48.34% | -13.0% |
| Q3 2020 | $303,752,000 | -99.9% | 3,631,656 | -13.2% | 55.60% | +25.9% |
| Q2 2020 | $307,413,373,000 | +73.5% | 4,183,064 | -0.5% | 44.16% | -9.1% |
| Q1 2020 | $177,224,616,000 | -30.8% | 4,205,615 | 0.0% | 48.60% | -37.0% |
| Q4 2019 | $256,142,982,000 | +47.6% | 4,205,615 | -0.7% | 77.19% | +15.0% |
| Q3 2019 | $173,546,331,000 | -13.3% | 4,233,870 | -0.4% | 67.15% | +15.2% |
| Q2 2019 | $200,122,625,000 | +31.9% | 4,248,888 | 0.0% | 58.31% | +16.6% |
| Q1 2019 | $151,770,279,000 | +47.2% | 4,248,888 | +17.7% | 50.00% | -2.0% |
| Q4 2018 | $103,105,530,000 | -35.6% | 3,608,874 | 0.0% | 51.04% | -6.2% |
| Q3 2018 | $160,053,562,000 | -24.5% | 3,608,874 | 0.0% | 54.44% | -17.7% |
| Q2 2018 | $212,057,436,000 | +0.7% | 3,608,874 | -21.7% | 66.16% | -1.8% |
| Q1 2018 | $210,551,322,000 | – | 4,606,242 | – | 67.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |